Non classé
AstraZeneca's Soriot warns new U.S. drug price law will hurt innovation
AstraZeneca’s Chief Executive Pascal Soriot warned on Tuesday new U.S. legislation capping drug prices would reduce the ability of companies to recoup their investment on developing new drugs and hurt innovation.
Source: SwissUXNews